Search

You searched for "care"

2573 results found

Efficacy and safety of intravitreal faricimab in nAMD, DME and RVO

30 January 2025 | | EYE - Vitreo-Retinal
This paper is an analysis of data extracted from 13 eligible studies in the context of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), collected from systematic literature search of MEDLINE, Embase, and Cochrane...

What’s Eating Gilbert Pete

2 August 2022 | | EYE - General
“Please phone Mr C Lyon ASAP on 0131 334 9171” This was a message from my secretary waiting for me on my computer one morning shortly after I was appointed a consultant. The name did not ring any bells but...

Cementing a VISION 2020 LINK partnership between Blantyre and Liverpool – building capacity for DR services alongside research

1 August 2016 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Malawi is a small land-locked country in eastern Africa with a growing population of over 17 million people. About 45% of the population is aged 14 or under; only 5% are aged 60 or over. The gross national income per...

Andean Medical Mission in action 2025

8 October 2025 | | international, AMM, charity, South America, glaucoma
Dear friends and supporters, What 12 months it has been for the Andean Medical Mission! Thanks to your encouragement and generosity, we’ve been able to continue our work to eliminate avoidable blindness in the Beni region of Bolivia — and...

From spine to eye: The benefits of multidisciplinary research

10 April 2025 | | EYE - Glaucoma, EYE - Neuro-ophthalmology
What have spinal and vision research got in common? More than you’d think. Dr Richard Eva. Funded by Fight for Sight, Dr Richard Eva came to vision from spinal cord research and is now co-lead on a project related to...

Fight for Sight continues to promote eye research

7 April 2020
Eye research charity Fight for Sight has announced its latest project funding and its plans for continuing its efforts to advance eye research in the current global health crisis and beyond.

Study shows laser treatment could significantly improve treatment for glaucoma in Africa

14 October 2021
Results of a trial published in Lancet Global Health on 14/10/21 could pave the way for significant improvements in treatment for glaucoma in Sub-Saharan Africa.

Professor Roy Taylor awarded MBE for services to diabetes research

20 January 2023
Congratulations to Diabetes UK-funded researcher Professor Roy Taylor, who has been awarded an MBE in the New Year Honours list, recognising his world-leading work in diabetes research.

Make eye drops a part of your Ramadan routine

21 March 2023 | glaucoma, Treatment, Eye drops, ramadan
Glaucoma UK, the Muslim Council of Britain (MCB), and the British Islamic Medical Association (BIMA) are encouraging Muslims with glaucoma to continue using their medication as prescribed during the holy month to prevent irreversible sight loss.

New Swansea eye hospital officially opened by Lord Mayor

6 April 2023 | spamedica, swansea, hospital
A new hospital specialising in NHS eye patient services has been officially opened by the Lord Mayor of Swansea, Councillor Mike Day.

New runners inspired by London Marathon warned to consider their eye health amid thousands of sign-ups ahead of the event

21 April 2023 | london, marathon, eyecare, eye health, optometrist
Runners and would-be runners have been urged to ensure they have considered the best options for their eyesight if they are inspired to be more active by this year’s London Marathon.

UK ophthalmologists discuss value of ultra-widefield multimodality retinal imaging

7 June 2023 | optomap, ophthalmology, ultra-widefield
Utilising optomap ultra-widefield (UWF™) multimodality retinal imaging with integrated SS (or SD) OCT in clinical practice contributes to identifying unexpected pathologies in a patient without visual complaints, report 81% of clinicians at industry webinar.